CLINDAMYCIN PHOSPHATE | N050639 | PFIZER INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services, Inc. FDA-2022-P-0475 · 3 docket documents Lachman Consultant Services, Inc. filed this petition requesting that the FDA determine whether Cleocin Phosphate in Dextrose 5% in Plastic Container (clindamycin injection in 5% dextrose) at three strengths, held under NDA N050639 by Pfizer Inc., was voluntarily withdrawn from the commercial market | 505(q) | 2022-03-30 | Denied | Lachman Consultant Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.